New Study on PTSD

BY TEXAS CANNABIS CLINIC

Texas Cannabis Clinic, Texas’ leading medical cannabis doctor, along with Texas Original dispensary (TXOG), released results in March 2022 from its clinical evaluation of their post-traumatic stress disorder (PTSD) focus group. Focus group participants sampled TXOG’s gummy, lozenge and tincture products at various dosages based on individual prescriptions from their physicians.

Dr. Brimberry’s 90 day PTSD focus group assessment noted the medicine was well tolerated and no patient discontinued treatment due to medicinal side effects.

Key findings from the assessment also included:

• Overall PTSD symptoms in the focus group were reduced 47% from an initial PCL-5 mean score of 54.3 to 28.6 after 90 days.

• 93% of patients experienced decreased symptom severity, while 86% of the group showed a clinically significant reduction in PTSD symptoms.

• At the end of the 90-day focus group, 71% of the group achieved PTSD remission—defined as a PCL-5 score of less than 33—while using TXOG’s product.

“My team and I have served hundreds of Texans suffering from PTSD, cancer and other debilitating conditions. Introducing medical cannabis into their treatment plans has been truly life-changing,” said Dr. Brimberry. “As a physician, my goal is to alleviate a patient’s symptoms to the best of my ability, improve their quality of life and better their long-term prognosis. To observe the participants of TXOG’s PTSD focus group experience such a dramatic, positive change in their symptoms has been extraordinary and conclusively demonstrates the impact medical cannabis can have in treatment.”

The focus group was composed exclusively of veterans clinically diagnosed with PTSD and were evaluated for: symptom response, patient product preference and medical cannabis’ potential to reduce traditional pharmaceutical consumption. Participants reported a reduction in pain, decreased nightmares, better sleep and improved mood while using TXOG’s medical cannabis products.

“This observational study echoes what veterans have been telling us. Medicinal cannabis should be considered as one of the first-line treatment options for PTSD. We are seeing significantly better results with cannabis when compared to conventional pharmacotherapy,” Dr. Brimberry added.